2
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Hyperthermia
22
Sarcoma
8
Uterine Cervical Neoplasms
7
Breast Neoplasms
6
Rectal Neoplasms
5
Prostatic Neoplasms
5
Ovarian Neoplasms
5
Colonic Neoplasms
5
Neoplasms
4
Neoplasm Metastasis
4
Head and Neck Neoplasms
4
Urinary Bladder Neoplasms
3
Melanoma
3
Lung Neoplasms
3
Carcinoma, Hepatocellular
3
Sarcoma, Synovial
2
Neurofibrosarcoma
2
Liver Neoplasms
2
Liposarcoma
2
Leiomyosarcoma
2
Histiocytoma, Malignant Fibrous
2
Fibrosarcoma
2
Colorectal Neoplasms
2
Carcinoma, Ovarian Epithelial
2
Unspecified Adult Solid Tumor, Protocol Specific
1
Squamous Cell Carcinoma of Head and Neck
1
Solid Tumors
1
Small Cell Lung Carcinoma
1
Sarcoma, Clear Cell
1
Sarcoma, Alveolar Soft Part
1
Interventions
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
15
Vaccines, Synthetic
10
Papillomavirus Vaccines
7
Vaccines
5
Imiquimod
4
Trichloroacetic Acid
3
Gels
3
human papillomavirus vaccine, L1 type 16, 18
2
green tea extract polyphenone E
2
Podophyllin
2
Human Papillomavirus Recombinant Vaccine nonavalent
2
Ethanol
2
Duration of Therapy
2
Cryotherapy
2
Cantharidin
2
ranpirnase
1
polyphenon E
1
nanocurcumin
1
hecolin
1
berdazimer sodium
1
Zinc
1
Viusid
1
Vaccination
1
VP-102
1
Tuberculin
1
Therapies, Investigational
1
Tea
1
Surgical Procedures, Operative
1
PRA1 protein, Candida albicans
1
Omiganan
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Condylomata Acuminata
×
Diathermy
×
Clear all
NCT03289260
2020-09-23
AdAM
Medical University Innsbruck
Phase 3
Unknown
200 enrolled